GUBRA.CO Overview

Company Profile

Related stocks

ZEAL.CO • Denmark

Zealand Pharma A/S

238 DKK

2.37B USD 1Y -53.5%

BSLN.SW • Switzerland

BASILEA N

65.5 CHF

977.91M USD 1Y +30.1%

PHARM.AS • Netherlands

PHARMING GROUP

0.88 EUR

695.09M USD 1Y -32.1%

PHM.MC • Spain

PHARMA MAR, S.A.

69.45 EUR

1.34B USD 1Y -21.3%

NANO.PA • France

NANOBIOTIX

21.24 EUR

1.21B USD 1Y -7.6%

IVA.PA • France

INVENTIVA

2.86 EUR

757.05M USD 1Y -38%

PHIL.MI • Italy

PHILOGEN

22 EUR

991.8M USD 1Y -5.4%

BAVA.CO • Denmark

Bavarian Nordic A/S

236.8 DKK

2.67B USD 1Y -0.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

69.2% p.a.

Max Drawdown (3Y)

-62.2%

Sharpe Ratio (3Y)

0.52

Beta Factor

0.45

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 162.6 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections